Boston Trust Walden Corp Lowers Holdings in Medtronic PLC $MDT

Boston Trust Walden Corp significantly reduced its stake in Medtronic PLC by 58.6% in the fourth quarter of 2025, selling over 30,000 shares. This comes as Medtronic slightly exceeded quarterly earnings expectations and provided FY2026 guidance, while analysts maintain a “Moderate Buy” consensus despite some trimming price targets. Institutional holdings remain high at 82.06%, though an EVP also reported a substantial sale of company stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin